Furthermore, endogenous cancer-associated fibroblast S100A4 functions to induce resistance to chemotherapeutic agents through myofibroblast transdifferentiation and resultant stiffening of the tumor stromal matrix (85). Here, S100A4 is linked to neoplasm.